Eric Nuermberger

Professor

19992019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Eric Nuermberger is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 22 Similar Profiles
Tuberculosis Medicine & Life Sciences
rifapentine Medicine & Life Sciences
Pyrazinamide Medicine & Life Sciences
Rifampin Medicine & Life Sciences
Mycobacterium tuberculosis Medicine & Life Sciences
Linezolid Medicine & Life Sciences
Multidrug-Resistant Tuberculosis Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2019

Activity of a long-acting injectable bedaquiline formulation in a paucibacillary mouse model of latent tuberculosis infection

Kaushik, A., Ammerman, N., Tyagi, S., Saini, V., Vervoort, I., Lachau-Durand, S., Nuermberger, E. & Andries, K., Apr 1 2019, In : Antimicrobial agents and chemotherapy. e00007-19.

Research output: Contribution to journalArticle

Open Access
bedaquiline
Latent Tuberculosis
Injections
rifapentine
Lung

Advancing the therapeutic potential of indoleamides for tuberculosis

Lun, S., Tasneen, R., Chaira, T., Stec, J., Onajole, O. K., Yang, T. J., Cooper, C. B., Mdluli, K., Converse, P. J., Nuermberger, E., Samuel Raj, V., Kozikowski, A. & Bishai, W. R., Jan 1 2019, In : Antimicrobial agents and chemotherapy. 63, 7, e00343-19.

Research output: Contribution to journalArticle

Open Access
Multidrug-Resistant Tuberculosis
Mycobacterium tuberculosis
Tuberculosis
Pharmacokinetics
Mycolic Acids

Advancing translational science for pulmonary nontuberculous mycobacterial infections: A road map for research

Daniel-Wayman, S., Abate, G., Barber, D. L., Bermudez, L. E., Coler, R. N., Cynamon, M. H., Daley, C. L., Davidson, R. M., Dick, T., Floto, R. A., Henkle, E., Holland, S. M., Jackson, M., Lee, R. E., Nuermberger, E., Olivier, K. N., Ordway, D. J., Prevots, D. R., Sacchettini, J. C., Salfinger, M. & 4 others, Sassetti, C. M., Sizemore, C. F., Winthrop, K. L. & Zelazny, A. M., Apr 15 2019, In : American journal of respiratory and critical care medicine. 199, 8, p. 947-951 5 p.

Research output: Contribution to journalReview article

Lung
Infection
Research

Contribution of pretomanid to novel regimens containing bedaquiline with either linezolid or moxifloxacin and pyrazinamide in murine models of tuberculosis

Xu, J., Li, S. Y., Almeida, D. V., Tasneen, R., Barnes-Boyle, K., Converse, P. J., Upton, A. M., Mdluli, K., Fotouhi, N. & Nuermberger, E., May 1 2019, In : Antimicrobial agents and chemotherapy. 63, 5, e00021-19.

Research output: Contribution to journalArticle

Open Access
Linezolid
bedaquiline
Pyrazinamide
Tuberculosis
Nude Mice

Dual β-lactam combinations highly active against mycobacterium abscessus complex in vitro

Pandey, R., Chen, L., Manca, C., Jenkins, S., Glaser, L., Vinnard, C., Stone, G., Lee, J., Mathema, B., Nuermberger, E., Bonomo, R. A. & Kreiswirth, B. N., Jan 1 2019, In : mBio. 10, 1, e02895-18.

Research output: Contribution to journalArticle

Open Access
Lactams
Ceftazidime
Mycobacterium
Imipenem
Anti-Bacterial Agents